Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06736951 · ClinicalTrials.gov registry record · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
A NA study of Delirium and Sleep Hygiene, sponsored by Farhaan S. Vahidy.
- Recruiting
- Registry status
- NA
- Development phase
- 10,890
- Enrollment target
- 5
- Study locations
NCT06736951: Recruiting NA study of Delirium and Sleep Hygiene, sponsored by Farhaan S. Vahidy.
NCT06736951 is a NA study of Delirium and Sleep Hygiene that is actively recruiting participants, run by Farhaan S. Vahidy. The registered enrollment target is 10,890 participants, above the 712-participant average among 62 other Delirium trials with a reported enrollment target (1429% higher). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06736951, a NA study of Delirium and Sleep Hygiene, is actively recruiting participants, sponsored by Farhaan S. Vahidy.
- RECRUITING
- Registry status
- NA
- Development phase
- 10,890 participants
- Enrollment target
- 5
- Study locations
Study Summary
The overall goal is to reduce the incidence and burden of delirium, as measured by the delirium burden index (DBI) among hospitalized older adults (≥70 years), by modifying the inpatient environment to decrease its sleep antagonism. The investigators propose to implement a multi-modal sleep hygiene (MMSH) bundle, an enhancement of a previously reported sleep-focused intervention which had 88 - 100% compliance for intervention components, and reduced ICU delirium by 50%.
Primary Outcome
Proportion of patients who develop HAD among those who did not have D-POA. D-POA is defined as 4AT positivity (at least one) during the first 48 hours of hospital admission. HAD is defined as 4AT positivity (at least one) after 48 hours of 4AT negatives.
Conditions Studied
Interventions
- OTHER MMSH (Multi-Modal Sleep Hygiene) Bundle
Study Locations (5)
Texas
- Houston Methodist Baytown Hospital - Baytown
- Houston Methodist Hospital - Houston
- Houston Methodist Research Institute - Houston
- Houston Methodist West Hospital - Houston
- Houston Methodist Sugarland Hospital - Sugarland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,890 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2029-03-31 |
| Phase | NA |
What NCT06736951 shows while recruiting
NCT06736951 is an interventional study that assigns participants to a tested intervention. Its 10,890 participants enrollment target places it among the larger protocols in the corpus, above the 712-participant average among 62 other Delirium trials with a reported enrollment target (1429% higher).
The record links to 2 conditions, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which MMSH (Multi-Modal Sleep Hygiene) Bundle is the first listed.
NCT06736951 lists 5 locations in 1 state (Texas).
Frequently Asked Questions
What is clinical trial NCT06736951 about?
NCT06736951 is a clinical study titled "Modifying the Inpatient Environment to Reduce Delirium in Older Adults". The overall goal is to reduce the incidence and burden of delirium, as measured by the delirium burden index (DBI) among hospitalized older adults (≥70 years), by modifying the inpatient environment to decrease its sleep antagonism. The investigators propose to implement a multi-modal sleep hygiene ...
What is the current status of trial NCT06736951?
This trial is currently recruiting. It is a NA study. The enrollment target is 10,890 participants. The study started on 2024-06-01. Estimated completion is 2029-03-31.
What conditions does trial NCT06736951 study?
This clinical trial studies the following conditions: Delirium, Sleep Hygiene.
What interventions are being tested in trial NCT06736951?
The interventions under investigation include: MMSH (Multi-Modal Sleep Hygiene) Bundle (OTHER).
Who is sponsoring clinical trial NCT06736951?
This trial is sponsored by Farhaan S. Vahidy, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06736951 being conducted?
This trial has 5 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06736951's enrollment target sits among peer trials
10,890 2nd of 62 the highest of 62 other Delirium trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Delirium trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
RECRUITING · NA
-
VoiceLove Digital Therapy for Delirium in the ICU
RECRUITING · NA
-
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
RECRUITING · NA
-
TaVNS for Delirium
RECRUITING · NA
-
Neurosteer Bedside Monitoring System
RECRUITING · NA
-
Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- NCT07181109 · 11,000 participants · Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI